Chimerix Inc (CMRX)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: PHARMACEUTICAL PREPARATIONS

2505 MERIDIAN PARKWAY, SUITE 100 DURHAM, NC 27713

Chimerix is a development-stage biopharmaceutical company dedicated to accelerating the advancement of innovative medicines that make a meaningful impact in the lives of patients living with cancer and other serious diseases. The company's three most advanced clinical-stage development programs are BCV, ONC201 and DSTAT. BCV is an antiviral drug candidate developed as a potential medical countermeasure for smallpox and is currently under review for regulatory approval in the United States. ONC201 is currently in a registrational clinical program for recurrent H3 K27M-mutant glioma and a confirmatory response rate assessment is expected later this year. DSTAT is in development as a potential first-line therapy in acute myeloid leukemia and as a potential treatment for acute lung injury in hospitalized COVID-19 patients.

Data as of 2021-07-25 17:01:14 -0400
Market Cap625.033 Million Shares Outstanding86.211 Million Avg 30-day Volume686.542 Thousand
P/E Ratio-4.7889 Dividend Yield0.0 EPS-1.95
Price/Sales114.15 Debt to Equity1.19 EBITDA-47.764 Million
Price to Book Value4.75 Forward PE0.56 Enterprise Value504.4 Million
Total Cash144.978 Million Current Debt22.248 Million Gross Profit5.566 Million
BETA1.31883 52-week High/Low11.57 / 2.22 Next Earnings Date2021-08-09 Price to Cash FLow (P/CF) -7.0359
Data provided by IEX Cloud
View SEC Filings from CMRX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 1 100.0% 2 (0.12%) 1 (0.06%) 100.0%
Funds Holding: 100 94 6.38% 35 (2.05%) 31 (1.8%) 12.9%
13F shares: 48.169 Million 28.75 Million 67.54% 30.384 Million 17.665 Million 72.0%
% Ownership 56.2202 45.9023 22.48% 35.462 28.203 25.74%
New Positions: 24 21 14.29% 12 4 200.0%
Increased Positions 41 22 86.36% 9 6 50.0%
Closed Positions 18 7 157.14% 8 4 100.0%
Reduced Positions 30 33 -9.09% 14 14 0.0%
Total Calls 253.777 Thousand 20.114 Thousand 1161.69% 190.2 Thousand
Total Puts 116.123 Thousand 76.418 Thousand 51.96% 15.1 Thousand
PUT/CALL Ratio 0.46 3.8 -87.89% 0.08 -97.89%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CMRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CMRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

10 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MIDDLETON FRED A

  • Director
3,518,923 2021-06-25 2

DEMSKI MARTHA J

  • Director
35,000 2021-06-23 5

GILLISS CATHERINE

  • Director
35,000 2021-06-23 1

MACHADO PATRICK

  • Director
35,000 2021-06-23 1

MEYER ROBERT J.

  • Director
35,000 2021-06-23 3

MULTANI PRATIK S

  • Director
35,000 2021-06-23 1

VAKIENER VICTORIA

  • Director
35,000 2021-06-23 3

JAKEMAN DAVID PRINCIPAL ACCOUNTING OFFICER

  • Officer
102,705 2021-04-05 5

SHERMAN MICHAEL A. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-01-22 1

ANDRIOLE MICHAEL T. CHIEF BUSINESS OFFICER AND CFO

  • Officer
0 2021-01-22 1

MELEMED ALLEN S. CHIEF MEDICAL OFFICER

  • Officer
0 2021-01-22 1

GREISSING ED

  • Director
0 2020-06-11 0

NICHOLS GARRETT CHIEF MEDICAL OFFICER

  • Officer
260,066 2020-02-07 0

CANTEX PHARMACEUTICALS, INC.

  • 10% Owner
0 2019-07-29 0

RENAUD RONALD C JR

  • Director
0 2019-06-20 0

DALY JAMES M

  • Director
0 2019-06-20 0

TROST TIMOTHY W. SVP, CFO & SECRETARY

  • Officer
217,088 2019-05-22 0

ALRUTZ MICHAEL ALBERT PRINCIPAL EXECUTIVE OFFICER

  • Officer
156,645 2019-02-05 0

BERREY M MICHELLE PRESIDENT AND CEO

  • Officer
  • Director
0 2019-01-23 0

MARIO ERNEST

  • Director
121,072 2018-05-17 0

RICHARDSON LINDA M CHIEF COMMERCIAL OFFICER

  • Officer
54,161 2018-05-14 0

NIEDEL JAMES

  • Director
0 2017-06-28 0

LEONARD JOHN M.

  • Director
0 2017-06-28 0

RICCIARDI LISA

  • Director
0 2016-06-24 0

ROGERS MICHAEL D. CHIEF DEVELOPMENT OFFICER

  • Officer
0 2016-01-08 0

WOLLAEGER TIMOTHY

  • Director
0 2015-06-22 0

SANDERLING VENTURE PARTNERS V, LP

  • 10% Owner
3,311,400 2014-09-12 0

SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

  • 10% Owner
697,346 2014-09-05 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MIDDLETON FRED A - Director

2021-06-29 17:37:18 -0400 2021-06-28 P 6,950 $7.83 a 207,523 direct 9.375 -4.5 9.375 2 -4.5 6

MIDDLETON FRED A - Director

2021-06-29 17:37:18 -0400 2021-06-25 P 3,050 $7.78 a 200,573 direct 9.375 -4.5 9.375 2 -4.5 6

MACHADO PATRICK - Director

2021-06-25 17:24:13 -0400 2021-06-23 A 35,000 a 35,000 direct

MULTANI PRATIK S - Director

2021-06-25 17:29:59 -0400 2021-06-23 A 35,000 a 35,000 direct

DEMSKI MARTHA J - Director

2021-06-25 17:21:21 -0400 2021-06-23 A 35,000 a 35,000 direct

MIDDLETON FRED A - Director

2021-06-25 17:28:11 -0400 2021-06-23 A 35,000 a 35,000 direct

GILLISS CATHERINE - Director

2021-06-25 17:22:58 -0400 2021-06-23 A 35,000 a 35,000 direct

MEYER ROBERT J. - Director

2021-06-25 17:25:49 -0400 2021-06-23 A 35,000 a 35,000 direct

VAKIENER VICTORIA - Director

2021-06-25 17:19:01 -0400 2021-06-23 A 35,000 a 35,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CHIMERIX INC CMRX 2021-07-28 16:15:02 UTC -0.6448 0.7248 2800000
CHIMERIX INC CMRX 2021-07-28 15:45:03 UTC -0.6448 0.7248 2800000
CHIMERIX INC CMRX 2021-07-28 15:15:03 UTC -0.6448 0.7248 2800000
CHIMERIX INC CMRX 2021-07-28 14:45:02 UTC -0.6472 0.7272 2800000
CHIMERIX INC CMRX 2021-07-28 14:15:03 UTC -0.6472 0.7272 2800000
CHIMERIX INC CMRX 2021-07-28 13:45:02 UTC -0.6472 0.7272 2800000
CHIMERIX INC CMRX 2021-07-28 13:15:03 UTC -0.6472 0.7272 2800000
CHIMERIX INC CMRX 2021-07-28 12:45:03 UTC -0.6472 0.7272 2800000
CHIMERIX INC CMRX 2021-07-27 22:15:03 UTC -0.6472 0.7272 2800000
CHIMERIX INC CMRX 2021-07-27 21:45:03 UTC -0.6472 0.7272 2800000
CHIMERIX INC CMRX 2021-07-27 21:15:03 UTC -0.6472 0.7272 2800000
CHIMERIX INC CMRX 2021-07-27 20:45:03 UTC -0.6421 0.7221 2800000
CHIMERIX INC CMRX 2021-07-27 20:15:03 UTC -0.6421 0.7221 2800000
CHIMERIX INC CMRX 2021-07-27 19:45:02 UTC -0.6421 0.7221 2800000
CHIMERIX INC CMRX 2021-07-27 19:15:02 UTC -0.6421 0.7221 2800000
CHIMERIX INC CMRX 2021-07-27 18:45:03 UTC -0.6421 0.7221 2800000
CHIMERIX INC CMRX 2021-07-27 18:15:02 UTC -0.6421 0.7221 2800000
CHIMERIX INC CMRX 2021-07-27 17:45:03 UTC -0.6421 0.7221 2800000
CHIMERIX INC CMRX 2021-07-27 17:15:03 UTC -0.6421 0.7221 2800000
CHIMERIX INC CMRX 2021-07-27 16:45:02 UTC -0.6421 0.7221 2800000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments